American International Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-754
| Closed | -$51K | – | 3350 |
|
2022
Q1 | $51K | Sell |
754
-53
| -7% | -$3.59K | ﹤0.01% | 2834 |
|
2021
Q4 | $98K | Sell |
807
-24
| -3% | -$2.91K | ﹤0.01% | 2728 |
|
2021
Q3 | $117K | Sell |
831
-20
| -2% | -$2.82K | ﹤0.01% | 2735 |
|
2021
Q2 | $234 | Buy |
851
+180
| +27% | +$49 | ﹤0.01% | 2409 |
|
2021
Q1 | $144 | Buy |
671
+90
| +15% | +$19 | ﹤0.01% | 2536 |
|
2020
Q4 | $140 | Sell |
581
-17
| -3% | -$4 | ﹤0.01% | 2478 |
|
2020
Q3 | $63K | Buy |
598
+170
| +40% | +$17.9K | ﹤0.01% | 2777 |
|
2020
Q2 | $42K | Buy |
428
+21
| +5% | +$2.06K | ﹤0.01% | 2938 |
|
2020
Q1 | $31K | Sell |
407
-23
| -5% | -$1.75K | ﹤0.01% | 2841 |
|
2019
Q4 | $35K | Sell |
430
-4
| -0.9% | -$326 | ﹤0.01% | 2955 |
|
2019
Q3 | $53K | Sell |
434
-3
| -0.7% | -$366 | ﹤0.01% | 2882 |
|
2019
Q2 | $78K | Sell |
437
-3
| -0.7% | -$535 | ﹤0.01% | 2803 |
|
2019
Q1 | $70K | Sell |
440
-14
| -3% | -$2.23K | ﹤0.01% | 2764 |
|
2018
Q4 | $118K | Buy |
454
+276
| +155% | +$71.7K | ﹤0.01% | 2505 |
|
2018
Q3 | $43K | Buy |
178
+3
| +2% | +$725 | ﹤0.01% | 3085 |
|
2018
Q2 | $41K | Buy |
+175
| New | +$41K | ﹤0.01% | 3015 |
|